MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/cid/cit808

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013

Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections.

Litvintseva Anastasia P, Lindsley Mark D, Gade Lalitha, Smith Rachel, Chiller Tom, Lyons Jennifer L, Thakur Kiran T, Zhang Sean X, Grgurich Dale E, Kerkering Thomas M, Brandt Mary E, Park Benjamin J

Оценочное исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The 2012 outbreak of fungal meningitis associated with contaminated methylprednisolone produced by a compounding pharmacy has resulted in >750 infections. An important question facing patients and clinicians is the duration of antifungal therapy. We evaluated (1-3)-β-d-glucan (BDG) as a marker for monitoring response to treatment.

METHODS

We determined sensitivity and specificity of BDG testing using the Fungitell assay, by testing 41 cerebrospinal fluid (CSF) specimens from confirmed cases of fungal meningitis and 66 negative control CSF specimens. We also assessed whether BDG levels correlate with clinical status by using incident samples from 108 case patients with meningitis and 20 patients with serially collected CSF.

RESULTS

A cutoff value of 138 pg/mL provided 100% sensitivity and 98% specificity for diagnosis of fungal meningitis in this outbreak. Patients with serially collected CSF were divided into 2 groups: those in whom BDG levels declined with treatment and those in whom BDG remained elevated. Whereas most patients with a decline in CSF BDG had clinical improvement, all 3 patients with continually elevated BDG had poor clinical outcomes (stroke, meningitis relapse, or development of new disease).

CONCLUSIONS

Our data suggest that measuring BDG in CSF is a highly sensitive test for diagnosis of fungal meningitis in this outbreak. Analysis of BDG levels in serially collected CSF demonstrated that BDG may correlate with clinical response. Routine measurement of BDG in CSF may provide useful adjunctive data for the clinical management of patients with outbreak-associated meningitis.

Для цитирования: Litvintseva Anastasia P, Lindsley Mark D, Gade Lalitha, Smith Rachel, Chiller Tom, Lyons Jennifer L, Thakur Kiran T, Zhang Sean X, Grgurich Dale E, Kerkering Thomas M, Brandt Mary E, Park Benjamin J. Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013. DOI: 10.1093/cid/cit808.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.